Skip to main content
. 2018 Dec 26;23(1):55–62. doi: 10.4196/kjpp.2019.23.1.55

Fig. 5. Effects of a 4-week repeated administration of HM41322 on body weight, blood glucose level, and glucose tolerance in db/db mice.

Fig. 5

HM41322 (0.1, 1, and 3 mg/kg) and dapagliflozin (1 mg/kg) were orally administered for 4 weeks. (A) Body weight and (B) blood glucose levels during the 4-week study. (C) Time-course changes in blood glucose during an OGTT at 24 h after the last administration. Data are expressed as mean±S.E.M., n =7.